Sauerbier, Anna, Bachon, Pia, Ambrosio, Leire, Loehrer, Philipp A., Rizos, Alexandra, Jost, Stefanie T., Gronostay, Alexandra, Konitsioti, Agni, Barbe, Michael T., Fink, Gereon R., Ashkan, Keyoumars, Nimsky, Christopher, Visser-vandewalle, Veerle, Chaudhuri, K. Ray, Timmermann, Lars, Martinez-Martin, Pablo and Dafsari, Haidar S. (2021) The new satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s Disease. Journal of Parkinson's Disease, 12 (1), 453-464. (doi:10.3233/JPD-212823).
Abstract
Background: the satisfaction with life and, in particular, with treatment in Parkinson’s disease (PD) is understudied. Objective: To explore a new 7-item rating tool assessing satisfaction with life and treatment (SLTS-7) in PD.
Methods: in this cross-sectional, multi-center study, including patients screened for advanced therapies, psychometric characteristics of the SLTS-7 were analyzed. An exploratory factor analysis identified the underlying factorial structure of the SLTS-7.
Results:117 patients were included, and the data quality of the SLTS-7 was excellent (computable data 100%), and acceptability measures satisfied standard criteria. Besides the global assessment (item 1), the exploratory factor analysis produced item 2 (physical satisfaction) as an independent item and two factors among the remaining items: items 3–5 (psycho-social satisfaction), and items 6 and 7 (treatment satisfaction). Cronbach’s alpha was 0.89, indicative of high internal consistency. The SLTS-7 total score correlated moderately with motor symptoms and weakly with non-motor symptoms total scores. SLTS-7 showed the highest correlations with the European Quality of Life with 5 items (EQ-5D) visual analog scale (0.43–0.58, p < 0.01), indicating a moderate convergent validity. The SLTS-7 significantly increased with higher non-motor symptoms burden levels (p = 0.002).
Conclusion: life satisfaction in PD covers three specific aspects, namely physical, psycho-social, and treatment satisfaction. The new SLTS-7 is a valid, reliable, and easy-to-use tool to assess satisfaction with life and treatment in patients with PD screened for advanced therapies. Longitudinal studies analyzing the effect of advanced PD treatment on life and treatment satisfaction are warranted.
More information
Identifiers
Catalogue record
Export record
Altmetrics
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.